Analysts Anticipate Nu Skin Enterprises, Inc. (NUS) Will Announce Quarterly Sales of $669.57 Million

Equities analysts expect Nu Skin Enterprises, Inc. (NYSE:NUS) to report sales of $669.57 million for the current quarter, Zacks reports. Two analysts have made estimates for Nu Skin Enterprises’ earnings, with estimates ranging from $666.16 million to $672.98 million. Nu Skin Enterprises posted sales of $531.33 million during the same quarter last year, which suggests a positive year-over-year growth rate of 26%. The firm is scheduled to issue its next quarterly earnings results after the market closes on Thursday, February 15th.

On average, analysts expect that Nu Skin Enterprises will report full-year sales of $669.57 million for the current fiscal year, with estimates ranging from $2.28 billion to $2.29 billion. For the next fiscal year, analysts forecast that the company will post sales of $2.36 billion per share, with estimates ranging from $2.34 billion to $2.37 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Nu Skin Enterprises.

NUS has been the topic of several research reports. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Citigroup reissued a “buy” rating and issued a $81.00 target price (up previously from $70.00) on shares of Nu Skin Enterprises in a report on Tuesday, January 23rd. Finally, Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Wednesday, December 20th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $65.38.

In other Nu Skin Enterprises news, Chairman Steven Lund sold 13,978 shares of the company’s stock in a transaction on Friday, January 19th. The stock was sold at an average price of $70.01, for a total value of $978,599.78. Following the sale, the chairman now owns 4,769 shares of the company’s stock, valued at $333,877.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 195,978 shares of company stock worth $13,512,733 in the last three months. 5.20% of the stock is owned by corporate insiders.

Large investors have recently modified their holdings of the company. Cerebellum GP LLC purchased a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at $124,000. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in shares of Nu Skin Enterprises in the third quarter valued at $148,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Nu Skin Enterprises by 38.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock valued at $210,000 after acquiring an additional 858 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at $220,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Nu Skin Enterprises in the third quarter valued at $219,000. Institutional investors and hedge funds own 78.00% of the company’s stock.

Nu Skin Enterprises (NYSE NUS) opened at $67.60 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $3,509.65, a price-to-earnings ratio of 24.76, a P/E/G ratio of 2.07 and a beta of 1.46. Nu Skin Enterprises has a twelve month low of $47.10 and a twelve month high of $74.45.

ILLEGAL ACTIVITY WARNING: This story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://sportsperspectives.com/2018/02/11/analysts-anticipate-nu-skin-enterprises-inc-nus-will-announce-quarterly-sales-of-669-57-million.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply